FRI-179 Early and Week 52 biomarker (MRI-PDFF, ALT, MRE and PRO-C3) responses to resmetirompredict improvements in MASH and liver fibrosis

Journal of Hepatology 2026

View at publisher

Authors: Rohit Loomba, Rebecca A. Taub, Krishna Padmanabhan, Dominic Labriola, Mazen Noureddin, Naim Alkhouri

DOI: 10.1016/s0168-8278(26)01917-3

Cited by: 1

Fields of Study & Subjects

Liver physiology and pathology Liver Disease Diagnosis and Treatment Liver Diseases and Immunity